News

In the rapidly evolving landscape of clinical trials, maintaining data integrity and minimizing bias while performing BICR (Blinded Independent Central Review) is paramount. The automation of reviewer performance monitoring through advanced platforms, complemented by artificial intelligence (AI), is revolutionizing the…   Read More

Prostate cancer is a significant health concern for men, being the most prevalent non-dermatologic cancer and the second leading cause of cancer-related deaths. Advances in imaging, particularly positron emission tomography (PET), along with radioligand therapy (RLT) using specific tracers, are…   Read More

Imaging plays a crucial role in pancreatic cancer clinical trials, particularly in the early diagnosis, monitoring, and treatment response evaluation. Often referred to as the "Silent Killer," it is a highly aggressive malignancy that often presents asymptomatically in its early…   Read More

Cervical cancer is a significant global health challenge, with over half a million new cases diagnosed annually. Ranking as the fourth most common cancer among women worldwide, its early detection and accurate staging are crucial. Magnetic resonance imaging (MRI) plays…   Read More

Chronic lymphocytic leukemia (CLL) is the most prevalent form of leukemia in adults, typically affecting those aged 65 years and older. While radiologic imaging is not considered as critical for initial diagnosis or during staging, it plays a crucial role…   Read More

At Clinical Endpoints, we are a Site Management Organization (SMO) that is dedicated to revolutionizing neurology research to enhance the lives of individuals with neurological disorders. Our focus spans various conditions, including Alzheimer’s and Parkinson’s disease, as we seek innovative…   Read More

Imaging is essential in hepatocellular carcinoma (HCC) clinical trials, guiding diagnosis and monitoring treatment efficacy. Among the most valuable tools are triphasic CT and/or MRI, which significantly improve diagnostic accuracy by differentiating liver tumors from surrounding tissues and assessing treatment…   Read More

Medical imaging is integral to the evolution of breast cancer clinical trials providing crucial insights into tumor detection and treatment evaluation. Mammography and ultrasound are the standard imaging modalities for screening and initial diagnosis, MRI helps determine the extent of…   Read More

Prostate cancer is the most common cancer among men and the second leading cause of cancer death after lung cancer. Advances in imaging techniques, particularly multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT (that Imaging Endpoints helped…   Read More

Lymphoma treatment is undergoing a remarkable transformation through the integration of advanced imaging biomarkers. Updated CT and PET response criteria are improving assessment strategies, while other functional imaging methods offer new insights into treatment efficacy. Amidst these technological advancements, bone…   Read More